SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients

BACKGROUND: Whether patients with autoimmune rheumatic diseases (ARD) have a higher risk for SARS-CoV-2 infection (COVID-19) and how SARS-CoV-2 pandemic impacts on adherence to therapy has not been fully elucidated. We assessed the rate and clinical presentation of COVID-19, and adherence to therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zen, M., Fuzzi, E., Astorri, D., Saccon, F., Padoan, R., Ienna, L., Cozzi, G., Depascale, R., Zanatta, E., Gasparotto, M., Benvenuti, F., Bindoli, S., Gatto, M., Felicetti, M., Ortolan, A., Campaniello, D., Larosa, M., Lorenzin, M., Ramonda, R., Sfriso, P., Schiavon, F., Iaccarino, L., Doria, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832807/
https://www.ncbi.nlm.nih.gov/pubmed/32527675
http://dx.doi.org/10.1016/j.jaut.2020.102502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832807/
https://www.ncbi.nlm.nih.gov/pubmed/32527675
http://dx.doi.org/10.1016/j.jaut.2020.102502

Ejemplares similares